NO20043209L - Fremstilling av A9 tetrahydrocannabinol - Google Patents
Fremstilling av A9 tetrahydrocannabinolInfo
- Publication number
- NO20043209L NO20043209L NO20043209A NO20043209A NO20043209L NO 20043209 L NO20043209 L NO 20043209L NO 20043209 A NO20043209 A NO 20043209A NO 20043209 A NO20043209 A NO 20043209A NO 20043209 L NO20043209 L NO 20043209L
- Authority
- NO
- Norway
- Prior art keywords
- acid
- thc
- converted
- tetrahydrocannabinol
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
- Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Saccharide Compounds (AREA)
- Electric Double-Layer Capacitors Or The Like (AREA)
- Optical Integrated Circuits (AREA)
- Steroid Compounds (AREA)
- Extraction Or Liquid Replacement (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0202396A GB0202396D0 (en) | 2002-02-01 | 2002-02-01 | Production of delta 9 tetrahydrocannabinol |
GB0214022A GB0214022D0 (en) | 2002-02-01 | 2002-06-18 | Production of delta 9 tetrahydrocannabinol |
PCT/GB2003/000441 WO2003064407A2 (en) | 2002-02-01 | 2003-02-03 | Production of δ9 tetrahydrocannabinol |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20043209L true NO20043209L (no) | 2004-10-28 |
Family
ID=27665366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20043209A NO20043209L (no) | 2002-02-01 | 2004-07-28 | Fremstilling av A9 tetrahydrocannabinol |
Country Status (17)
Country | Link |
---|---|
US (3) | US7524881B2 (zh) |
EP (2) | EP1474412B1 (zh) |
JP (1) | JP2005526715A (zh) |
CN (2) | CN1642934A (zh) |
AT (1) | ATE396984T1 (zh) |
AU (2) | AU2003205844B2 (zh) |
BR (1) | BR0307330A (zh) |
CA (1) | CA2474951A1 (zh) |
DE (2) | DE60332776D1 (zh) |
DK (1) | DK1474412T3 (zh) |
ES (1) | ES2305437T3 (zh) |
NO (1) | NO20043209L (zh) |
NZ (2) | NZ552547A (zh) |
PT (1) | PT1474412E (zh) |
SI (1) | SI1474412T1 (zh) |
WO (1) | WO2003064407A2 (zh) |
ZA (1) | ZA200405938B (zh) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2474951A1 (en) * | 2002-02-01 | 2003-08-07 | Resolution Chemicals Limited | Production of .delta.9 tetrahydrocannabinol |
CA2455129C (en) * | 2002-08-14 | 2013-10-22 | Gw Pharma Limited | Improvements in the extraction of pharmaceutically active components from plant materials |
GB2391865B (en) * | 2002-08-14 | 2005-06-01 | Gw Pharma Ltd | Improvements in the extraction of pharmaceutically active components from plant materials |
GB2408978B (en) * | 2002-09-23 | 2006-04-05 | Gw Pharma Ltd | Methods of preparing delta-9 tetrahydrocannabinol from plant material |
GB0222077D0 (en) | 2002-09-23 | 2002-10-30 | Gw Pharma Ltd | Methods of preparing cannabinoids from plant material |
TWI436991B (zh) | 2004-11-22 | 2014-05-11 | Euro Celtique Sa | 用於純化反-(-)-△9-四氫大麻酚與反-(+)-△9-四氫大麻酚之方法 |
CN101132781A (zh) * | 2004-12-09 | 2008-02-27 | 茵西斯医疗公司 | 在室温下稳定的屈大麻酚剂型 |
TWI366460B (en) | 2005-06-16 | 2012-06-21 | Euro Celtique Sa | Cannabinoid active pharmaceutical ingredient for improved dosage forms |
KR20080063800A (ko) * | 2005-09-29 | 2008-07-07 | 에이엠알 테크놀로지, 인크. | 델타-9-테트라히드로칸나비놀의 제조 방법 |
US20080112895A1 (en) * | 2006-08-04 | 2008-05-15 | Insys Therapeutics Inc. | Aqueous dronabinol formulations |
US20080103193A1 (en) * | 2006-10-26 | 2008-05-01 | Trevor Percival Castor | Methods for making compositions and compositions for treating pain and cachexia |
GB0703284D0 (en) | 2007-02-20 | 2007-03-28 | Resolution Chemicals Ltd | Delta 9 - tetrahydrocannabinol processing |
WO2009020666A1 (en) * | 2007-08-06 | 2009-02-12 | Insys Therapeutics Inc. | Oral cannabinoid liquid formulations and methods of treatment |
US20090042974A1 (en) * | 2007-08-07 | 2009-02-12 | Anson David Parker | Compositions And Methods Relating To Extensible Transgenic Vector Assembler, Pestilence Ridder, Plus Cannabinoid Producer |
GB0807915D0 (en) * | 2008-05-01 | 2008-06-04 | Resolution Chemicals Ltd | Production of delta 9 tetrahydrocannabinol |
US8343553B2 (en) | 2011-04-18 | 2013-01-01 | Hospodor Andrew D | Essential element extractor |
WO2013045115A1 (de) * | 2011-09-29 | 2013-04-04 | The Health Concept Gmbh | Cannabinoidcarbonsäuren, salze von cannabinoidcarbonsäuren, deren herstellung und anwendungen |
US9358259B2 (en) | 2012-03-20 | 2016-06-07 | Andrew David Hospodor | Recycling cannabinoid extractor |
DK2844243T3 (da) * | 2012-05-03 | 2020-02-03 | Echo Pharmaceuticals Bv | Fremgangsmåde til fremstilling af et cannabisplante-isolat omfattende delta-9-tetrahydrocannabinol |
US20130337052A1 (en) * | 2012-06-19 | 2013-12-19 | Patricia Linert | System and Method of Reducing Impairment of Alertness, Concentration, Motivation, and Creativity Caused by Medication |
US9155767B2 (en) | 2012-10-18 | 2015-10-13 | Andrew D. Hospodor | Essential element management |
US10792318B2 (en) | 2013-03-14 | 2020-10-06 | Sc Laboratories, Inc. | Bioactive concentrates and uses thereof |
US9199960B2 (en) * | 2013-05-02 | 2015-12-01 | Frederick R. Ferri | Method and apparatus for processing herbaceous plant materials including the cannabis plant |
US9220294B2 (en) | 2014-02-11 | 2015-12-29 | Timothy McCullough | Methods and devices using cannabis vapors |
US10821240B2 (en) | 2014-02-11 | 2020-11-03 | Vapor Cartridge Technology Llc | Methods and drug delivery devices using cannabis |
US9380813B2 (en) | 2014-02-11 | 2016-07-05 | Timothy McCullough | Drug delivery system and method |
US20170312327A1 (en) * | 2014-11-17 | 2017-11-02 | Connoisseur Holdings, Llc | Extraction devices, systems, and methods |
US10207198B2 (en) * | 2015-01-22 | 2019-02-19 | Phytoplant Research S.L. | Methods of purifying cannabinoids using liquid:liquid chromatography |
BR112017015536B1 (pt) * | 2015-01-22 | 2021-05-18 | Phytoplant Research S.L | métodos de purificação de canabinoides |
US11034639B2 (en) | 2015-01-22 | 2021-06-15 | Phytoplant Research S.L. | Methods of purifying cannabinoids using liquid:liquid chromatography |
US11040295B2 (en) | 2015-02-06 | 2021-06-22 | Joseph Francis Payack | Method and apparatus for extracting plant oils using ethanol water |
WO2016179247A1 (en) * | 2015-05-07 | 2016-11-10 | Axim Biotechnologies, Inc. | Process to extract and purify delta-9-tetrahydrocannabinol |
US10913071B2 (en) | 2016-03-09 | 2021-02-09 | Pearson Incorporated | Scalper apparatus and processing system |
US10499584B2 (en) | 2016-05-27 | 2019-12-10 | New West Genetics | Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles |
WO2018000094A1 (en) | 2016-06-29 | 2018-01-04 | CannScience Innovations Inc. | Decarboxylated cannabis resins, uses thereof and methods of making same |
BR112019000816B1 (pt) * | 2016-07-15 | 2021-07-20 | S.S. Steiner, Inc. | Descarboxilação de ácido canabidiólico em biomassa de cânhamo e extrato de cânhamo |
US10322487B1 (en) | 2016-07-15 | 2019-06-18 | Pearson Incorporated | Roller mill grinding apparatus with regenerative capability |
US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
US10702495B2 (en) | 2017-02-20 | 2020-07-07 | Nexien Biopharma, Inc. | Method and compositions for treating dystrophies and myotonia |
IT201700085508A1 (it) * | 2017-07-26 | 2019-01-26 | Inalco S R L | Metodo per la produzione di cannabinoidi da varietà di canapa industriale |
US10807098B1 (en) | 2017-07-26 | 2020-10-20 | Pearson Incorporated | Systems and methods for step grinding |
US10272360B2 (en) | 2017-08-05 | 2019-04-30 | Priya Naturals, Inc. | Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto |
US10406453B2 (en) * | 2017-09-29 | 2019-09-10 | NextLeaf Solutions Ltd. | Cannabinoid extraction process using brine |
US10941102B2 (en) * | 2017-11-29 | 2021-03-09 | Robert Henry Wohleb | Aqueous leaching method to produce microcrystalline powder |
MX2020007960A (es) * | 2018-01-29 | 2020-09-24 | Phytoplant Res S L | Metodos para purificar cannabinoides usando cromatografia liquido-liquido. |
CA3089994A1 (en) | 2018-01-31 | 2019-08-08 | Canopy Holdings, LLC | Hemp powder |
US11325133B1 (en) | 2018-07-26 | 2022-05-10 | Pearson Incorporated | Systems and methods for monitoring the roll diameter and shock loads in a milling apparatus |
EP3870199A1 (en) * | 2018-09-17 | 2021-09-01 | Sorbent Technologies, Inc. | Methods for removing contaminants from plant-derived pharmaceuticals |
US11040932B2 (en) | 2018-10-10 | 2021-06-22 | Treehouse Biotech, Inc. | Synthesis of cannabigerol |
US10751722B1 (en) | 2018-10-24 | 2020-08-25 | Pearson Incorporated | System for processing cannabis crop materials |
EP3911148A4 (en) * | 2019-01-17 | 2022-10-12 | Synthonics, Inc. | SOLID MICELLAR COMPOSITIONS OF CANNABINOID ACIDS |
US10785906B2 (en) | 2019-02-19 | 2020-09-29 | Pearson Incorporated | Plant processing system |
CA3134805A1 (en) * | 2019-03-24 | 2020-10-01 | Omega Life Science Ltd. | Electronic cigarettes |
US20200323791A1 (en) | 2019-04-11 | 2020-10-15 | Mantrose-Haueser Co., Inc. | Cannabis delivery with protective glaze coating |
US11370767B2 (en) | 2019-04-23 | 2022-06-28 | Soma Oil Llc | Cannabis processing systems and methods |
EP3750528A1 (en) | 2019-06-11 | 2020-12-16 | Nexien Biopharma, Inc. | Compositions for treating dystrophies and myotonia |
WO2021055079A1 (en) | 2019-09-16 | 2021-03-25 | Vapor Cartridge Technology Llc | Drug delivery system with stackable substrates |
US10757860B1 (en) | 2019-10-31 | 2020-09-01 | Hemp Processing Solutions, LLC | Stripper apparatus crop harvesting system |
US10933424B1 (en) | 2019-12-11 | 2021-03-02 | Pearson Incorporated | Grinding roll improvements |
CN111039760A (zh) * | 2019-12-16 | 2020-04-21 | 福建省中科生物股份有限公司 | 一种制备酚类化合物的方法 |
US11351476B2 (en) * | 2020-01-07 | 2022-06-07 | Agrify Corporation | Method for chemical separation of cannabinoids |
CA3179204A1 (en) * | 2020-06-09 | 2021-12-16 | David A. Fisher | Process for isolation and purification of thca from cannabis |
US20230270806A1 (en) | 2020-09-04 | 2023-08-31 | Herbolea Biotech S.P.A. | Thc-free cannabinoid concentrate, method of obtaining the same and use thereof |
US12029718B2 (en) | 2021-11-09 | 2024-07-09 | Cct Sciences, Llc | Process for production of essentially pure delta-9-tetrahydrocannabinol |
US11242328B1 (en) * | 2021-02-25 | 2022-02-08 | Acid Neutral Alkaline Laboratory | Heterogeneous catalyst and method for preparation of aromatic tricyclic pyrans |
US11352337B1 (en) * | 2021-06-02 | 2022-06-07 | Acid Neutral Alkaline Laboratory | Zeolite catalyst and method for preparation of aromatic tricyclic pyrans |
CN115260005B (zh) * | 2022-08-30 | 2024-01-30 | 晨光生物科技集团股份有限公司 | 一种纯化提取大麻二酚的方法与应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5342971A (en) * | 1992-12-29 | 1994-08-30 | The Australian National University | Process for the preparation of dibenzo[b,d]pyrans |
AU703958B2 (en) | 1995-05-05 | 1999-04-01 | Hauser Inc. | High purity carnosic acid from rosemary and sage extracts by PH-controlled precipitation |
GB9726916D0 (en) * | 1997-12-19 | 1998-02-18 | Danbiosyst Uk | Nasal formulation |
US20020039795A1 (en) * | 1998-10-26 | 2002-04-04 | Elsohly Et Al | Method of preparing delta-9-tetrahydrocannabinol |
US6730519B2 (en) * | 1998-10-26 | 2004-05-04 | The University Of Mississippi | Method of preparing delta-9-tetrahydrocannabinol |
CA2474951A1 (en) * | 2002-02-01 | 2003-08-07 | Resolution Chemicals Limited | Production of .delta.9 tetrahydrocannabinol |
-
2003
- 2003-02-03 CA CA002474951A patent/CA2474951A1/en not_active Abandoned
- 2003-02-03 US US10/503,082 patent/US7524881B2/en not_active Expired - Lifetime
- 2003-02-03 DK DK03702721T patent/DK1474412T3/da active
- 2003-02-03 NZ NZ552547A patent/NZ552547A/en not_active IP Right Cessation
- 2003-02-03 CN CNA038074168A patent/CN1642934A/zh active Pending
- 2003-02-03 ES ES03702721T patent/ES2305437T3/es not_active Expired - Lifetime
- 2003-02-03 AU AU2003205844A patent/AU2003205844B2/en not_active Ceased
- 2003-02-03 CN CNA2007100073695A patent/CN100999513A/zh active Pending
- 2003-02-03 DE DE60332776T patent/DE60332776D1/de not_active Expired - Lifetime
- 2003-02-03 AT AT03702721T patent/ATE396984T1/de not_active IP Right Cessation
- 2003-02-03 WO PCT/GB2003/000441 patent/WO2003064407A2/en active IP Right Grant
- 2003-02-03 SI SI200331290T patent/SI1474412T1/sl unknown
- 2003-02-03 BR BR0307330-0A patent/BR0307330A/pt active Search and Examination
- 2003-02-03 DE DE60321318T patent/DE60321318D1/de not_active Expired - Lifetime
- 2003-02-03 NZ NZ534430A patent/NZ534430A/en not_active IP Right Cessation
- 2003-02-03 JP JP2003564030A patent/JP2005526715A/ja active Pending
- 2003-02-03 PT PT03702721T patent/PT1474412E/pt unknown
- 2003-02-03 EP EP03702721A patent/EP1474412B1/en not_active Expired - Lifetime
- 2003-02-03 EP EP07005421A patent/EP1803717B1/en not_active Expired - Lifetime
-
2004
- 2004-07-26 ZA ZA200405938A patent/ZA200405938B/en unknown
- 2004-07-28 NO NO20043209A patent/NO20043209L/no not_active Application Discontinuation
- 2004-07-30 US US10/902,698 patent/US7592468B2/en not_active Expired - Lifetime
-
2006
- 2006-12-29 AU AU2006252300A patent/AU2006252300B2/en not_active Ceased
-
2009
- 2009-06-18 US US12/487,185 patent/US20090253783A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003064407A2 (en) | 2003-08-07 |
AU2003205844B2 (en) | 2006-10-12 |
US7524881B2 (en) | 2009-04-28 |
US20050049298A1 (en) | 2005-03-03 |
US20050171361A1 (en) | 2005-08-04 |
PT1474412E (pt) | 2008-07-04 |
CA2474951A1 (en) | 2003-08-07 |
NZ552547A (en) | 2008-03-28 |
ZA200405938B (zh) | 2006-05-31 |
CN1642934A (zh) | 2005-07-20 |
EP1803717A3 (en) | 2007-07-11 |
DE60332776D1 (de) | 2010-07-08 |
US7592468B2 (en) | 2009-09-22 |
SI1474412T1 (sl) | 2008-10-31 |
DE60321318D1 (de) | 2008-07-10 |
JP2005526715A (ja) | 2005-09-08 |
WO2003064407A3 (en) | 2003-10-16 |
EP1474412B1 (en) | 2008-05-28 |
EP1803717A2 (en) | 2007-07-04 |
DK1474412T3 (da) | 2008-09-01 |
CN100999513A (zh) | 2007-07-18 |
NZ534430A (en) | 2007-09-28 |
AU2006252300A1 (en) | 2007-01-25 |
AU2006252300B2 (en) | 2009-02-12 |
US20090253783A1 (en) | 2009-10-08 |
BR0307330A (pt) | 2004-12-07 |
EP1803717B1 (en) | 2010-05-26 |
EP1474412A2 (en) | 2004-11-10 |
ES2305437T3 (es) | 2008-11-01 |
ATE396984T1 (de) | 2008-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20043209L (no) | Fremstilling av A9 tetrahydrocannabinol | |
NO20062092L (no) | Nye fremgangsmater for fremstilling av N-desmetylzopiklon og optisk rent (+)-N-desmetylzopiklon og optisk rent (-)-N-desmetylzopiklon | |
BRPI0318811B8 (pt) | derivados de ciclohexanol espirocíclicos | |
BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
BR0312695A (pt) | Derivados de 1h-pirrolidina-2,4-diona espirocìclicos substituìdos por cis-alcóxi | |
ECSP056016A (es) | Nuevos derivados de 2-piridinacarboxamida | |
NO20051038L (no) | Nye effektorkonjugater, fremgangsmate for deres fremstilling, og deres farmasoytiske bruk | |
WO2001089571A3 (en) | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | |
ATE252571T1 (de) | Tocotrienole und geranylgeraniol aus nebenprodukten von bixa orellana | |
SI1745010T1 (sl) | Substituirani cikloheksil-1,4-diaminski derivati | |
UY26133A1 (es) | Derivado sustituido de pirazol. | |
AR029795A1 (es) | Derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico sustituidos, procedimientos para su preparacion, su uso para la preparacion de medicamentos y medicamentos que contienen estos compuestos | |
UY26951A1 (es) | Derivados de ácido propiónico | |
MXPA04006803A (es) | Derivados de acidos alfa-feniltiocarboxilicos y alfa-feniloxi-carboxilicos para tratamiento de enfermedades que responden a activacion del receptor alfa activado del proliferador de peroxisoma. | |
ES2187483T3 (es) | Procedimiento para la preparacion de acido a-lipoico esento de disolvente. | |
WO2003029391A1 (fr) | Procede de production de compositions de matiere grasse renfermant de l'acide oleanolique et/ou de l'acide maslinique | |
BR0309357A (pt) | Método para fabricar cristais de esteróides, cristais obtìveis de acordo com esse método, e formulações farmacêuticas | |
IT1319195B1 (it) | Processo per la produzione dell'acido r(+)alfa-lipoico. | |
NO20052329D0 (no) | Fremgangsmate for rensingen av 1,4-butandiol-mononitrat | |
PT1309535E (pt) | Processo para a preparação de alfa¿-clorocetonas | |
EP1258478A4 (en) | PROCESS FOR THE PREPARATION OF CHINOLONCARBOXYLIC ACIDS AND THEIR INTERMEDIATE PRODUCTS | |
BR0116918A (pt) | Preparação de warfarin sódico a partir do ácido de warfarin | |
ES2146772T3 (es) | Derivados de imidoacidos y su empleo como pesticidas. | |
DE60222945D1 (de) | Verfahren zur herstellung von cefpodoxim-proxetil | |
ES8800200A1 (es) | Un proceso para produccion de un derivado del indol. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |